Apimeds (APUS): Nilai Total Aset Perusahaan

Apimeds Pharmaceuticals (APUS) is developing a comprehensive approach to the therapy of sclerosis and inflammatory processes, establishing a foundation for saving critically ill patients. Business development relies on the promotion of purified bee venom injections under strict monitoring of trial costs, with total assets amounting to 69.09. The linear price action on this chart is supplemented by data on the implementation of computer biomodeling and robotics to automate drug development.

Total Aset Perusahaan Apimeds Pharmaceuticals US (APUS): kanggo periode 10.05.2025 - 29.10.2026

Rincian metrik komprehensif lan analitis apimedsus.com (APUS)

- rega lan prakiraan konsensus rega:

Bagan bursa Apimeds Pharmaceuticals US|APUS - Bagan rega target

- data kapitalisasi pasar:

Biji pasar Apimeds Pharmaceuticals, Inc.|APUS - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi Saham Apimeds Pharmaceuticals|APUS - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku apimedsus.com|APUS - Aset Agregat Perusahaan

- data utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Apimeds Pharmaceuticals|APUS - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Apimeds Pharmaceuticals US|APUS - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Apimeds Pharmaceuticals, Inc.|APUS - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Apimeds Pharmaceuticals

Pambiji fundamental:APUS, Apimeds

Produk dadi Apimeds Pharmaceuticals, Inc.

A stable cash flow from the sale of bee venom-based drugs forms the foundation of the capital base of Apimeds Pharmaceuticals (APUS). Total assets, reconstructed via ROA profitability, reflect the company's aggregate resource volume, where a lack of dynamics in the change of the company's financial assets signals business stagnation despite the current stability of operational activities.

Pesaing Apimeds Pharmaceuticals (APUS)

JAZZ (jazzpharma.com) - Gunggung Aset Perusahaan|Aset Agregat Perusahaan Cytokinetics, Incorporated CYTK|Nilai Total Aset Perusahaan PTC Therapeutics Inc|Scholar Rock Corp (SRRK) - Total Aset Perusahaan|Nilai Agregat Aset Centessa Corp (CNTA)|Total Aset Perusahaan DYN (Dyne Therapeutics, Inc.)|edgewisetx.com - Total Aset Perusahaan|Aset Agregat Perusahaan Rapport Therapeutics (RAPP)|ALMS: Nilai Agregat Aset|ZVRA (Kempharm) - Aset Agregat Perusahaan|Contineum Corp (CTNM) - Gunggung Aset Perusahaan|LRMR (Larimar Therapeutics) - Total Aset Perusahaan|Total Aset Perusahaan Capricor (CAPR)|Entrada Therapeutics, Inc. (TRDA) - Gunggung Aset Perusahaan|Nilai Agregat Aset PTHS (Channel Therapeutics Inc.)|MNOV - Aset Agregat Perusahaan|Total Aset Bisnis Serina Pharma SER|BTAI (BioXcel Therapeutics) - Total Aset Perusahaan|ProMIS Neurosciences (PMN) - Aset Perusahaan|AEON: Gunggung Aset Perusahaan|NLSP (NLS Pharmaceutics) - Total Aset Perusahaan|BNOX - Aset Agregat Perusahaan|Nilai Agregat Aset HUGE|Reata Pharmaceuticals - Aset Agregat Perusahaan